Skip to main content
    Experts InSight
    Comprehensive Ophthalmology, Retina/Vitreous

    Drs. M. Ali Khan, Ajay Kuriyan, and Sarah Read join host Jay Sridhar to discuss recent developments in intravitreal injectable drugs, including 8-mg aflibercept not initially approved by the FDA, the upcoming PDUFA date for on-label bevacizumab, and approaching injections for dry age-related macular degeneration (AMD).

    For all episodes or to claim CME credit for selected episodes, visit